22562 Federal Register / Vol. 74, No. 91 / Wednesday, May 13, 2009 / Notices 

Dated: May 5, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–11005 Filed 5–12–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Advisory Commission on Childhood 

Vaccines; Notice of Meeting 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), notice is hereby given 

of the following meeting: 

Name: Advisory Commission on 

Childhood Vaccines (ACCV). 

Date and Time: June 4, 2009, 1 pm to 5:30 

pm EDT. June 5, 2009, 9 a.m. to 12 p.m. EDT. 

Place: Parklawn Building (and via audio 

conference call), Conference Rooms G & H, 

5600 Fishers Lane, Rockville, MD 20857. 

The ACCV will meet on Thursday, June 4 

from 1 pm to 5:30 pm (EDT) and Friday, June 

5 from 9 a.m. to 12 p.m. (EDT). The public 

can join the meeting via audio conference 

call by dialing 1–888–790–1959 on June 4 & 

5 and providing the following information: 

Leader’s Name: Dr. Geoffrey Evans. 

Password: ACCV. 

Agenda: The agenda items for the June 

meeting will include, but are not limited to: 

Updates from the Division of Vaccine Injury 

Compensation (DVIC), Department of Justice, 

National Vaccine Program Office, 

Immunization Safety Office (Centers for 

Disease Control and Prevention), National 

Institute of Allergy and Infectious Diseases 

(National Institutes of Health), Center for 

Biologics, Evaluation and Research (Food 

and Drug Administration), an update from 

the IOM on the project to review adverse 

effects of vaccines, and a final report from 

Altarum Institute on the Petitioner’s 

Satisfaction Survey. Agenda items are subject 

to change as priorities dictate. 

Public Comments: Persons interested in 

providing an oral presentation should submit 

a written request, along with a copy of their 

presentation to: Michelle Herzog, DVIC, 

Healthcare Systems Bureau (HSB), Health 

Resources and Services Administration 

(HRSA), Room 11C–26, 5600 Fishers Lane, 

Rockville, Maryland 20857 or e-mail: 

mherzog@hrsa.gov. Requests should contain 

the name, address, telephone number, and 

any business or professional affiliation of the 

person desiring to make an oral presentation. 

Groups having similar interests are requested 

to combine their comments and present them 

through a single representative. The 

allocation of time may be adjusted to 

accommodate the level of expressed interest. 

DVIC will notify each presenter by mail or 

telephone of their assigned presentation time. 

Persons who do not file an advance request 

for a presentation, but desire to make an oral 

statement, may announce it at the time of the 

comment period. These persons will be 

allocated time as it permits. 

For Further Information Contact: Anyone 

requiring information regarding the ACCV 

should contact Michelle Herzog, DVIC, HSB, 

HRSA, Room 11C–26, 5600 Fishers Lane, 

Rockville, MD 20857; telephone (301) 443– 

6593 or e-mail: mherzog@hrsa.gov. 

Dated: May 5, 2009. 

Alexandra Huttinger, 

Director, Division of Policy Review and 

Coordination. 

[FR Doc. E9–11084 Filed 5–12–09; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Task Force on Community Preventive 

Services 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting: 

Name: Task Force on Community 

Preventive Services. 

Times and Dates: 8 a.m.–6 p.m. EST, June 

17, 2009; 8 a.m.–1 p.m. EST, June 18, 2009. 

Place: Centers for Disease Control and 

Prevention, 2500 Century Parkway, Room 

1200/1201, Atlanta, Georgia 30345. 

Status: Open to the public, limited only by 

the space available. 

Purpose: The mission of the Task Force is 

to develop and publish the Guide to 

Community Preventive Services (Community 

Guide), which consists of systematic reviews 

of the best available scientific evidence and 

associated recommendations regarding what 

works in the delivery of essential public 

health services. 

Topics include: 

—Interventions to increase vaccination 

coverage in children, adolescents, and 

adults: An Update ‘‘of’’ the vaccination 

requirements review 

—Using Population Levels of Alcohol 

Consumption as an Indicator of Excessive 

Alcohol Consumption and Related Harms 

—Group-based Interventions to Prevent 

Adolescent Pregnancy, HIV, Other 

Sexually Transmitted Infections: A 

Systematic Review and Meta-analyses 

—Update on the Community Guide Web site 

—VPD Updates: School-based Vaccination 

Programs 

—Mass Media Campaigns to Increase 

Physical Activity 

—Technology-based Strategies to Prevent 

and/or Control Obesity: Technology-based 

Multi-component Counseling 

Agenda items are subject to change as 

priorities dictate. 

Persons interested in reserving a space for 

this meeting should call Charmen Crawford 

at 404–498–2498. 

Contact person for additional information: 

Charmen Crawford, Coordinating Center for 

Health Information and Services, National 

Center for Health Marketing, Office of the 

Director, 1600 Clifton Road, M/S E–69, 

Atlanta, GA 30329, phone: 404–498–2498. 

Dated: May 6, 2009. 

James D. Seligman, 

Chief Information Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. E9–11138 Filed 5–12–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, 

National Center for Environmental 

Health/Agency for Toxic Substances 

and Disease Registry (BSC, NCEH/ 

ATSDR) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), CDC and NCEH/ 

ATSDR announce the following meeting 

of the aforementioned committee: 

Times and Dates: 8:30 a.m.–4 p.m., May 

28, 2009. 8:30 a.m.–12:15 p.m., May 29, 2009. 

Place: Centers for Disease Control and 

Prevention, 4770 Buford Highway, Atlanta, 

Georgia 30341. 

Status: Open to the public, limited only by 

the space available. The meeting room 

accommodates approximately 75 people. 

Purpose: The Secretary, Department of 

Health and Human Services (HHS) and by 

delegation, the Director, CDC and 

Administrator, ATSDR, are authorized under 

Section 301 (42 U.S.C. 241) and Section 311 

(42 U.S.C. 243) of the Public Health Service 

Act, as amended, to: (1) Conduct, encourage, 

cooperate with, and assist other appropriate 

public authorities, scientific institutions, and 

scientists in the conduct of research, 

investigations, experiments, demonstrations, 

and studies relating to the causes, diagnosis, 

treatment, control, and prevention of 

physical and mental diseases and other 

impairments; (2) assist states and their 

political subdivisions in the prevention of 

infectious diseases and other preventable 

conditions and in the promotion of health 

and well being; and (3) train state and local 

personnel in health work. The BSC, NCEH/ 

ATSDR provides advice and guidance to the 

Secretary, HHS; the Director, CDC and 

Administrator, ATSDR; and the Director, 

NCEH/ATSDR, regarding program goals, 

objectives, strategies, and priorities in 

fulfillment of the agency’s mission to protect 

and promote people’s health. The board 

provides advice and guidance that will assist 

NCEH/ATSDR in ensuring scientific quality, 

timeliness, utility, and dissemination of 

results. The board also provides guidance to 

help NCEH/ATSDR work more efficiently 

and effectively with its various constituents 

and to fulfill its mission in protecting 

America’s health. 

Matters To Be Discussed: The agenda items 

will include updates by the Director of